비교리스트

 카트 문의
시장보고서
상품코드
1610011

광학 전임상 이미징 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Optical Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (Device, Consumables), By End-use (Pharma and Biotech Companies, Research Institutes), By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

광학 전임상 이미징 시장 성장과 동향

Grand View Research, Inc의 새로운 보고서에 따르면, 세계 광학 전임상 이미징 시장 규모는 연평균 4.2%의 CAGR로 성장하여 2030년 말까지 8억 560만 달러에 달할 것으로 예상됩니다. 다양한 질병에 대한 다양한 효과적인 치료법을 연구하고 개발하기 위한 전임상 연구의 증가는 광학 전임상 이미징 시스템의 채택을 촉진하는 주요 요인입니다.

예를 들어, 2018년 12월 인도에 본사를 둔 신약개발 스타트업인 버그웍스 리서치(Bugworks Research)는 보스턴에 본사를 둔 기관인 CARB-X로부터 300만 달러의 보조금을 받았습니다. 이 보조금은 항균제 내성을 퇴치하기 위한 새로운 분자의 전임상 트레일 개발을 지원하기 위해 제공되었습니다. 또한 다양한 연구자들은 암 임상시험의 실패율을 줄이기 위해 전임상 암 연구의 재현성과 견고성을 향상시키는 새로운 방법을 찾기 위해 노력하고 있습니다. 또한, 광학 이미징은 PET 및 MRI 시스템과 같은 소동물 분자 이미징 기술과 비교하여 비용 효율적이고 고성능의 동물 실험이 가능합니다.

광학 전임상 이미징 시장 보고서 하이라이트

  • 연구 인프라 구축, 전임상 연구 가이드라인 채택, 제품 승인, R&D 프로젝트 수 증가로 인해 북미가 2024년 가장 큰 점유율을 차지했습니다.
  • 제품별로 보면 장치 부문에서는 다양한 연구에 사용되는 동물 이미징을 위한 다른 기술에 비해 높은 감도와 넓은 다이나믹 레인지로 인해 2024년 광학 전임상 이미징 시장에서 가장 큰 점유율을 차지한 것은 바이오루미네이션입니다.
  • 최종 용도별로는 제약 및 생명공학 기업 부문이 2024년 광학 전임상 이미징 시장에서 가장 큰 점유율을 차지했는데, 이는 제약 및 바이오테크 기업 부문의 신약 개발 연구 후보군 수 증가와 신약 개발 및 혁신을 위한 R&D에 대한 중요성이 높아졌기 때문입니다.
  • 연구기관 부문은 연구기관에서 첨단 광학 이미징 시스템 채택이 증가함에 따라 예측 기간 동안 가장 빠른 성장세를 보일 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 광학 전임상 이미징 시장 변수, 동향, 범위

  • 시장 계통 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 비즈니스 환경 분석
    • 산업 분석 - Porter's Five Forces 분석
    • PESTLE 분석

제4장 광학 전임상 이미징 시장 : 제품 비즈니스 분석

  • 제품 시장 점유율, 2024년과 2030년
  • 제품 부문 대시보드
  • 시장 규모와 예측과 동향 분석, 제품별, 2018-2030년
  • 디바이스
  • 소모품
  • 소프트웨어

제5장 광학 전임상 이미징 시장 : 최종 용도 비즈니스 분석

  • 최종 용도 시장 점유율, 2024년과 2030년
  • 최종 용도 부문 대시보드
  • 시장 규모와 예측과 동향 분석, 최종 용도별, 2018-2030년
  • 제약·바이오테크놀러지 기업
  • 연구기관
  • 기타

제6장 광학 전임상 이미징 시장 : 제품, 최종 용도, 지역별, 추정·동향 분석

  • 지역별 시장 점유율 분석, 2024년과 2030년
  • 지역별 시장 대시보드
  • 시장 규모, 예측 동향 분석, 2018-2030년
  • 북미
    • 국가별, 2018-2030년
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 국가별, 2018-2030년
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 노르웨이
    • 덴마크
    • 스웨덴
  • 아시아태평양
    • 국가별, 2018-2030년
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 국가별, 2018-2030년
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 국가별, 2018-2030년
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제7장 경쟁 구도

  • 참여자 개요
  • 기업의 시장 포지션 분석
  • 기업 분류
  • 전략 매핑
  • 기업 개요/상장 기업
    • Bruker
    • PerkinElmer
    • MR Solutions
    • BioTek Instruments, Inc.
    • MILabs BV
    • Magnetic Insight, Inc.
    • MBF Bioscience
    • FUJIFILM Corporation
    • Mediso Ltd.
ksm 25.01.03

Optical Preclinical Imaging Market Growth & Trends:

The global optical preclinical imaging market size is expected to reach USD 805.6 million by the end of 2030, expanding at a CAGR of 4.2%, according to a new report by Grand View Research, Inc. Increasing number of preclinical studies aimed to study and develop various effective therapeutics for different diseases is a major factor boosting the adoption of optical preclinical imaging systems.

For instance, in December 2018, Bugworks Research, a drug discovery startup based in India, received US$ 3 million grant from CARB-X, a Boston-based organization. The grant was offered to support the development of preclinical trail for novel molecules to fight antimicrobial resistance. Moreover, various researchers are engaged in finding novel ways to increase the reproducibility and robustness of preclinical cancer research with an aim to reduce the failure rate of oncology clinical trials. Optical imaging also allows cost-effective and high-throughput animal study as compared to small animal molecular imaging technologies, including PET and MRI systems.

Optical Preclinical Imaging Market Report Highlights:

  • North America accounted for the largest share in 2024 owing to well-established research infrastructure, adoption of guidelines for preclinical research, product approvals, and higher number of drug development projects
  • Based on product type, in the device segment, bioluminescence captured the largest optical preclinical imaging market share in 2024 owing to high sensitivity and broad dynamic range as compared to other techniques for imaging animals used in various studies
  • By end use, the pharma and biotech companies segment accounted for the largest optical preclinical imaging market share in 2024 owing to increasing number of candidates in drug development studies and increasing focus on research and development for drug development and innovation
  • The research institutes segment is expected to witness the fastest growth during the forecast period owing to rising adoption of advanced optical imaging systems in the research institutes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Optical Preclinical Imaging Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Optical Preclinical Imaging Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Device
    • 4.4.1. Device Market, 2018 - 2030 (USD Million)
    • 4.4.2. Fluorescence
      • 4.4.2.1. Fluorescence Market, 2018 - 2030 (USD Million)
    • 4.4.3. Bioluminescence
      • 4.4.3.1. Bioluminescence Market, 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables Market, 2018 - 2030 (USD Million)
    • 4.5.2. Fluorescence
      • 4.5.2.1. Fluorescence Market, 2018 - 2030 (USD Million)
      • 4.5.2.2. Green Fluorescent Proteins
        • 4.5.2.2.1. Green Fluorescent Proteins Market, 2018 - 2030 (USD Million)
      • 4.5.2.3. Red Fluorescent Proteins
        • 4.5.2.3.1. Red Fluorescent Proteins Market, 2018 - 2030 (USD Million)
      • 4.5.2.4. Infrared Dyes
        • 4.5.2.4.1. Infrared Dyes Market, 2018 - 2030 (USD Million)
      • 4.5.2.5. Others
        • 4.5.2.5.1. Others Market, 2018 - 2030 (USD Million)
    • 4.5.3. Bioluminescence
      • 4.5.3.1. Bioluminescence Market, 2018 - 2030 (USD Million)
      • 4.5.3.2. Luciferins
        • 4.5.3.2.1. Luciferins Market, 2018 - 2030 (USD Million)
      • 4.5.3.3. Proluciferins
        • 4.5.3.3.1. Proluciferins Market, 2018 - 2030 (USD Million)
      • 4.5.3.4. Coelenterazine
        • 4.5.3.4.1. Coelenterazine Market, 2018 - 2030 (USD Million)
      • 4.5.3.5. Others
        • 4.5.3.5.1. Others Market, 2018 - 2030 (USD Million)
  • 4.6. Software
    • 4.6.1. Software Market, 2018 - 2030 (USD Million)

Chapter 5. Optical Preclinical Imaging Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Pharma and Biotech Companies
    • 5.4.1. Pharma and Biotech Companies Market, 2018 - 2030 (USD Million)
  • 5.5. Research Institutes
    • 5.5.1. Research Institutes Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Optical Preclinical Imaging Market: Regional Estimates & Trend Analysis by Product and End Use

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Optical Preclinical Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Optical Preclinical Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Optical Preclinical Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Optical Preclinical Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Optical Preclinical Imaging Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Optical Preclinical Imaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Bruker
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. PerkinElmer
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. MR Solutions
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. BioTek Instruments, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. MILabs B.V.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Magnetic Insight, Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. MBF Bioscience
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. FUJIFILM Corporation
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Mediso Ltd.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제